Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Highlight Therapeutics (Spain) | Researchclopedia

Back to institutions

Highlight Therapeutics (Spain)

Paternacompany

60

Works

2,185

Citations

21

h-index

Top Research Topics

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses CAR-T cell therapy research

Top Researchers

Juan Manuel García‐Ruiz Centro de Estudios Políticos y Constitucionales

509 works11,894 citationsh-index: 57

Recent Research

439TiP ROSETTA Lung-01: A phase III, two-stage trial of pumitamig, a PD-L1 × VEGF-A bispecific antibody, plus chemotherapy versus atezolizumab + chemotherapy as first-line treatment in patients with extensive-stage small cell lung cancer

M. Reck,Özgür ÖZYILKAN,et al.

20260 citations

RNA Interference and Gene Delivery

Cancer-related molecular mechanisms research

CRISPR and Genetic Engineering

Immune Cell Function and Interaction

Virus-based gene therapy research

HER2/EGFR in Cancer Research

Proteoglycans and glycosaminoglycans research

Nanoparticle-Based Drug Delivery

Antibiotic Resistance in Bacteria

Mercedes Pozuelo-Rubio

13 works10,217 citationsh-index: 8

Helena Escuin-Ordinas Highlight Therapeutics (Spain)

67 works8,116 citationsh-index: 18

Xavier Barril Institució Catalana de Recerca i Estudis Avançats

186 works7,259 citationsh-index: 43

Carmen Llena Universitat de València

254 works4,269 citationsh-index: 37

Pilar Domingo‐Calap Universitat de València

102 works3,692 citationsh-index: 29

149TiP ROSETTA Lung-02: A global phase II/III, randomized, open-label trial of pumitamig, a PD-L1 × VEGF-A bispecific antibody, in combination with chemotherapy in patients (pts) with first-line non-small cell lung cancer

S. Peters,Y. Lee,et al.

20260 citations

Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 results

J. Deng,Aastha Pal,et al.

20260 citations

Arbovirus persistence in mosquitoes is characterized by translation repression of viral RNAs

Marc Talló-Parra,Mireia Puig-Torrents,et al.

20260 citations

Abstract PD3-05: Targeting FGFR4 with an antibody-drug conjugate in hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer progressing to CDK4/6 inhibitors and endocrine therapy

F. Brasó-Maristany,N. Lorman-Carbó,et al.

20260 citations

In vivo CAR-T: a paradigm shift in adoptive cell therapy from bench to beside

Yuanting Cai,Huilei Miao,et al.

20260 citations